HALISTER: Actavis’s New CEO Says ‘Zero Plans’ to Sell Despite Deal History

Actavis’s New CEO Says ‘Zero Plans’ to Sell Despite Deal History

Alert: HALISTER Source: BN (Bloomberg News)

Tickers ACT US (Actavis plc) FRX US (Forest Laboratories Inc) VRX CN (Valeant Pharmaceuticals International Inc)

People Brenton Saunders (Forest Laboratories Inc) C Nicholson (Bayer Cropscience) Corey Davis (Canaccord Genuity Corp) Marshall Gordon (ClearBridge Investments LLC) Paul Bisaro (Actavis plc)

Topics CEO Interviews

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283